Drug recall: Glenmark recalls 6,528 bottles of this BP drug

April 17, 2024

317

Table of Contents

Last Updated on October 9, 2024 by The Health Master

Drug recall

High Blood Pressure (High BP) drug Recall, also known as hypertension drug recall, is a critical public health update for individuals taking medication to manage their blood pressure.

This article details a recent drug recall of a specific blood pressure medication by Glenmark Pharmaceuticals due to concerns about its effectiveness.

Follow us on WhtasApp Channel

Glenmark Recalls Diltiazem Hcl Capsules

According to a recent Enforcement Report by the U.S. Food and Drug Administration (USFDA), Glenmark Pharmaceuticals, a major pharmaceutical company, is recalling 6,528 bottles of their Diltiazem Hydrochloride extended-release capsules.

Diltiazem Hydrochloride is a medication prescribed to treat high blood pressure (high BP hypertension).

Reason for the Drug Recall: Failed Dissolution Specifications

The USFDA cites “failed dissolution specifications” as the reason behind the drug recall. Dissolution refers to the process by which a medication breaks down and releases its active ingredients into the body.

Medications are expected to maintain consistent dissolution rates throughout their shelf life.

In this case, a test conducted at the 12th month mark of a long-term stability study revealed that the Diltiazem Hydrochloride capsules did not meet the required dissolution specifications.

Click for more articles on USFDA

Potential Impact of the Drug Recall

The USFDA has classified this drug recall as a Class II recall.

This classification signifies that the use of the affected medication may cause temporary or reversible health issues.

There’s a remote possibility of serious health consequences.

However, it’s crucial for patients taking the recalled medication to consult their healthcare provider to discuss alternative treatment options to ensure uninterrupted blood pressure management.

What to Do if You Have the Recalled Medication

Identify the Batch Number: The drug recall affects only specific batches of Diltiazem Hydrochloride capsules. Check the medication bottle for the batch number and expiration date.
Stop Taking the Medication: If you have a bottle included in the drug recall, discontinue taking the medication immediately.
Contact Your Doctor: Schedule an appointment with your doctor to discuss alternative treatment options for managing your blood pressure.
Return the Medication: Follow Glenmark Pharmaceuticals’ instructions for returning the recalled medication.

Glenmark Initiates Nationwide Drug Recall

Glenmark Pharmaceuticals initiated a nationwide Class II recall of the affected Diltiazem Hydrochloride capsules across the US on March 26, 2024.

Patients with any questions or concerns regarding the drug recall can contact Glenmark Pharmaceuticals.

Maintaining Blood Pressure Control is Essential

High blood pressure (high BP) is a significant health concern that can lead to serious health complications if left untreated.

It’s vital for individuals taking medication for hypertension to ensure they are receiving effective treatment.

If you have any concerns about your blood pressure medication or have been taking the recalled Diltiazem Hydrochloride capsules, consult your healthcare provider for guidance and alternative treatment options.

Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.